Disseminated Polyomavirus Infection in Chronic Lymphocytic Leukemia (CLL) Following Salvage Chemo-Immunotherapy

A.C. Black; C. Khanna; V.M. Assomull; D.R. Gadowski; J.L. Barstis; W.G. Clough

JOURNAL

Lymphoma and Chronic Lymphocytic Leukemias

Disseminated Polyomavirus Infection in Chronic Lymphocytic Leukemia (CLL) Following Salvage Chemo-Immunotherapy

Submit a Paper

A.C. Black,, C. Khanna, V.M. Assomull, D.R. Gadowski, J.L. Barstis, and W.G. Clough

Lymphoma and Chronic Lymphocytic Leukemias 2010:2 7-10

Case report

Published on 15 Dec 2010

DOI: 10.4137/LCLL.S5877

Further metadata provided in PDF

Download Article PDF

Sign up for email alerts to receive notifications of new articles published in Lymphoma and Chronic Lymphocytic Leukemias

Abstract and Sharing
Article Metrics
Discuss

Abstract

Chemo-immunotherapy treatment for chronic lymphocytic leukemia (CLL) induces high response rates and improves progression free (PFS) and overall survival (OS) as compared to chemotherapy alone. The fludarabine, cyclophosphamide, and rituximab (FCR) regimen is a standard first line and salvage treatment for CLL. However, FCR is associated with significant immunosupression and an increased risk of opportunistic infections (Ols). Here, we report a case of disseminated polyomavirus infection despite standard anti-infective prophylaxis in a relapsed CLL patient in a sustained clinical complete remission (CR) after FCR therapy.

Downloads

PDF (416.64 KB PDF FORMAT)

RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation (BIBDESK, LATEX)

What Your Colleagues Say About Libertas Academica

I recommend highly Clinical Medicine Insights: Endocrinology and Diabetes as it provides guidance in each step of the publication process. The peer review was also in high quality yet very constructive.

Dr Stanley Kim MD (Keck School of Medicine, University of Southern California, USA)

More Testimonials